CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy

Matthew Ho, Luca Paruzzo, Julia Han Noll, Federico Stella, Pooja Devi, Sonia Ndeupen, Yael A. Day, Gregory M. Chen, Ivan Cohen, Ángel Ramírez-Fernández, Adam Waxman, Shivani Kapur, Fang Chen, Rong Xu, Andrew Huff, Danuta Jarocha, Vrutti Patel, Audrey Bochi-Layec, Ranjani Ramasubramanian, S. Liu, Riemke Bouvier, Vitor B. de Souza, Heta Patel, Z. Li, Alberto Carturan, Peter Michener, Caitlin R. Hopkins, Owen Koucky, Janna Minehart, Alex Dimitri, Neel R. Nabar, Zainul S. Hasanali, Bryan T. Ciccarelli, Putzer Hung, Erik Williams, Robert L. Bartoszek, Maya Lavorando, Mohan Suyash, Vanessa Gonzalez, Patrizia Porazzi, Vijay Bhoj, Sokratis A. Apostolidis, Dan T. Vogl, David L. Porter, John Scholler, Caroline Diorio, Aoife M. Roche, J.K. Everett, Frederic D. Bushman, Katherine L. Nathanson, Stadtmauer Ea, Sandra P. Susanibar-Adaniya, Alfred L. Garfall, Marco Antonio Ruella, Adam D. Cohen, Joseph A. Fraietta